- Home
- FCUV vs CVKD Comparison
FCUV vs CVKD Comparison
Compare FCUV & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCUV
- CVKD
- Stock Information
- Founded
- FCUV 2012
- CVKD 2022
- Country
- FCUV United States
- CVKD United States
- Employees
- FCUV N/A
- CVKD N/A
- Industry
- FCUV Industrial Machinery/Components
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- FCUV Industrials
- CVKD Health Care
- Exchange
- FCUV Nasdaq
- CVKD Nasdaq
- Market Cap
- FCUV 27.6M
- CVKD 29.5M
- IPO Year
- FCUV N/A
- CVKD 2023
- Fundamental
- Price
- FCUV $2.52
- CVKD $10.81
- Analyst Decision
- FCUV
- CVKD Strong Buy
- Analyst Count
- FCUV 0
- CVKD 1
- Target Price
- FCUV N/A
- CVKD $32.00
- AVG Volume (30 Days)
- FCUV 20.5K
- CVKD 28.9K
- Earning Date
- FCUV 08-13-2025
- CVKD 08-06-2025
- Dividend Yield
- FCUV N/A
- CVKD N/A
- EPS Growth
- FCUV N/A
- CVKD N/A
- EPS
- FCUV N/A
- CVKD N/A
- Revenue
- FCUV $408,887.00
- CVKD N/A
- Revenue This Year
- FCUV N/A
- CVKD N/A
- Revenue Next Year
- FCUV N/A
- CVKD N/A
- P/E Ratio
- FCUV N/A
- CVKD N/A
- Revenue Growth
- FCUV 6.49
- CVKD N/A
- 52 Week Low
- FCUV $1.50
- CVKD $5.70
- 52 Week High
- FCUV $10.90
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- FCUV 30.15
- CVKD 38.21
- Support Level
- FCUV $2.68
- CVKD $11.25
- Resistance Level
- FCUV $3.16
- CVKD $11.88
- Average True Range (ATR)
- FCUV 0.30
- CVKD 0.76
- MACD
- FCUV -0.06
- CVKD -0.02
- Stochastic Oscillator
- FCUV 20.49
- CVKD 7.46
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.